Wall Street Experts
ver. ZuMIgo(08/25)
Prognozy (mln) dla ASKA Pharmaceutical Holdings Co.,Ltd.
Okres |
2023-03-31 |
2024-03-31 |
2025-03-31 |
2026-03-31 |
2027-03-31 |
2028-03-31 |
2029-03-31 |
Przychód (średnia) |
60,300.00 |
62,843.00 |
64,484.33 |
66,979.96 |
70,742.00 |
76,369.00 |
78,635.00 |
Przychód Δ r/r |
0.00% |
4.22% |
2.61% |
3.87% |
5.62% |
7.95% |
2.97% |
Przychód (min) |
58,372.41 |
62,296.80 |
63,544.26 |
63,721.64 |
68,480.62 |
73,927.74 |
76,121.31 |
Przychód (max) |
62,223.01 |
63,677.20 |
65,414.39 |
70,238.29 |
72,998.01 |
78,804.46 |
81,142.72 |
EBITDA (średnia) |
7,854.68 |
8,185.93 |
8,399.73 |
8,724.82 |
9,214.86 |
9,947.83 |
10,243.00 |
EBIT (średnia) |
4,507.41 |
4,697.50 |
4,820.18 |
5,006.73 |
5,287.94 |
5,708.56 |
5,877.94 |
EBIT % |
7.47% |
7.47% |
7.47% |
7.47% |
7.47% |
7.47% |
7.47% |
Zysk netto (średni) |
4,255.50 |
7,545.00 |
5,111.00 |
5,329.00 |
6,307.00 |
6,458.28 |
6,325.21 |
Zysk netto % |
7.06% |
12.01% |
7.93% |
7.96% |
8.92% |
8.46% |
8.04% |
EPS (średnia) |
150.30 |
266.48 |
180.55 |
188.26 |
222.80 |
228.10 |
223.40 |
Liczba analityków (Przychody) |
1 |
3 |
2 |
2 |
2 |
0 |
1 |
Liczba analityków (EPS) |
0 |
3 |
2 |
2 |
2 |
1 |
0 |
symbol |
4886.T |
4886.T |
4886.T |
4886.T |
4886.T |
4886.T |
4886.T |